126 related articles for article (PubMed ID: 11922394)
1. Identification of semaphorin3B as a direct target of p53.
Ochi K; Mori T; Toyama Y; Nakamura Y; Arakawa H
Neoplasia; 2002; 4(1):82-7. PubMed ID: 11922394
[TBL] [Abstract][Full Text] [Related]
2. hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53.
Kimura T; Gotoh M; Nakamura Y; Arakawa H
Cancer Sci; 2003 May; 94(5):431-6. PubMed ID: 12824889
[TBL] [Abstract][Full Text] [Related]
3. Cyclin K as a direct transcriptional target of the p53 tumor suppressor.
Mori T; Anazawa Y; Matsui K; Fukuda S; Nakamura Y; Arakawa H
Neoplasia; 2002; 4(3):268-74. PubMed ID: 11988847
[TBL] [Abstract][Full Text] [Related]
4. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses.
Yoon KA; Nakamura Y; Arakawa H
J Hum Genet; 2004; 49(3):134-140. PubMed ID: 14986171
[TBL] [Abstract][Full Text] [Related]
5. Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53.
Shiraishi K; Fukuda S; Mori T; Matsuda K; Yamaguchi T; Tanikawa C; Ogawa M; Nakamura Y; Arakawa H
Cancer Res; 2000 Jul; 60(14):3722-6. PubMed ID: 10919640
[TBL] [Abstract][Full Text] [Related]
6. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.
Yoon H; Liyanarachchi S; Wright FA; Davuluri R; Lockman JC; de la Chapelle A; Pellegata NS
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15632-7. PubMed ID: 12438652
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.
Tomizawa Y; Sekido Y; Kondo M; Gao B; Yokota J; Roche J; Drabkin H; Lerman MI; Gazdar AF; Minna JD
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13954-9. PubMed ID: 11717452
[TBL] [Abstract][Full Text] [Related]
9. CDC20, a potential cancer therapeutic target, is negatively regulated by p53.
Kidokoro T; Tanikawa C; Furukawa Y; Katagiri T; Nakamura Y; Matsuda K
Oncogene; 2008 Mar; 27(11):1562-71. PubMed ID: 17873905
[TBL] [Abstract][Full Text] [Related]
10. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
[TBL] [Abstract][Full Text] [Related]
11. Analysis of SEMA3B methylation and expression patterns in gastric cancer tissue and cell lines.
Chen R; Zhuge X; Huang Z; Lu D; Ye X; Chen C; Yu J; Lu G
Oncol Rep; 2014 Mar; 31(3):1211-8. PubMed ID: 24402303
[TBL] [Abstract][Full Text] [Related]
12. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
Sheikh MS; Burns TF; Huang Y; Wu GS; Amundson S; Brooks KS; Fornace AJ; el-Deiry WS
Cancer Res; 1998 Apr; 58(8):1593-8. PubMed ID: 9563466
[TBL] [Abstract][Full Text] [Related]
13. SEMA3B improves the survival of patients with esophageal squamous cell carcinoma by upregulating p53 and p21.
Tang H; Wu Y; Liu M; Qin Y; Wang H; Wang L; Li S; Zhu H; He Z; Luo J; Wang H; Wang Q; Luo S
Oncol Rep; 2016 Aug; 36(2):900-8. PubMed ID: 27349960
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
Anticancer Res; 2001; 21(1A):189-95. PubMed ID: 11299733
[TBL] [Abstract][Full Text] [Related]
16. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines.
Mukhopadhyay T; Roth JA
Anticancer Res; 1996; 16(1):105-12. PubMed ID: 8615594
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independent response to ultraviolet irradiation.
Takahashi S; Saito S; Ohtani N; Sakai T
Cancer Res; 2001 Feb; 61(3):1187-95. PubMed ID: 11221850
[TBL] [Abstract][Full Text] [Related]
19. Role of human HGFIN/nmb in breast cancer.
Metz RL; Patel PS; Hameed M; Bryan M; Rameshwar P
Breast Cancer Res; 2007; 9(5):R58. PubMed ID: 17845721
[TBL] [Abstract][Full Text] [Related]
20. AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression.
Li J; Jiang P; Robinson M; Lawrence TS; Sun Y
Carcinogenesis; 2003 May; 24(5):827-34. PubMed ID: 12771025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
